Diagnostics and therapy of chronic pancreatitis according to UEG guidelines
Authors:
Lumír Kunovský 1,2,3; Petr Dítě 1,4,5; Martina Bojková 4,5; Jiří Dolina 1,3; Jitka Vaculová 1,3; Hana Kolovratníková 1,3; Magdalena Uvírová 6; Pavel Janeček 2,3; Zdeněk Kala 2,3; Petr Jabandžiev 3,7,8
Authors‘ workplace:
Interní gastroenterologická klinika, Fakultní nemocnice Brno
1; Chirurgická klinika, Fakultní Nemocnice Brno
2; Lékařská fakulta Masarykovy Univerzity, Brno
3; Interní klinika, Fakultní nemocnice Ostrava
4; Lékařská fakulta Ostravské univerzity, Ostrava
5; CGB Laboratoř Ostrava
6; Pediatrická klinika, Fakultní nemocnice Brno
7; Středoevropský technologický institut (CEITEC), Masarykova univerzita, Brno
8
Published in:
Vnitř Lék 2021; 67(2): 85-91
Category:
Main Topic
Overview
Chronic pancreatitis is one of the diseases whose incidence is slightly increasing long-term. Apparently this is related to our current dietary habits and to the way of life in industrialized societies in general.
In recent years, chronic pancreatitis has experienced greater diagnostic accuracy and reliability, although we are still unable to diagnose the early stages of the disease. In diagnostics, sophisticated imaging methods are in the forefront, and less frequent is the use of tests that assess the exocrine function of the gland.
Non-invasive therapeutic approaches include dietary measures, including an absolute ban on alcohol. Drug therapy consists of the application of drugs containing pancreatic digestive enzymes and the treatment of pancreatic pain. The administration of capsules containing microparticles containing pancreatic enzymes, protected against inactivation of enzymes in an acidic gastric environment, is effective.
In the treatment of pancreatic pain, we use a range of analgesic drugs, but abstinence from alcohol itself leads to a decrease in the frequency of pancreatic pain. Surgical therapy is very effective. Among other treatment methods include also endoscopic therapy. From the point of view of diagnosis and therapy, chronic pancreatitis is one of the conditions requiring a multidisciplinary approach. In this review article, we discuss the possibilities of diagnosis and treatment of chronic pancreatitis according to the current recommendations of UEG (United European Gastroenterology).
Keywords:
chronic pancreatitis – TIGAR‑ O classification – Pancreas – exocrine pancreatic insufficiency – pancreatic pain – United European Gastroenterology
Sources
1. Dítě P, Starý K, Novotný I et al. The Incidence of chronic pancreatitis in the Czech Republic. Eur J Gastroenterol Hepatol 2001; 13(6): 749–750.
2. Yadav D, Timmons L, Benson JT et al. Incidence, prevalence and survival of chronic pancreatitis: a population‑based study. Am J Gastroenterol 2011; 106: 2192–2199.
3. Lévy P, Domínguez‑Muñoz E, Imrie C et al. Epidemiology of chronic pancreatitis: burden of the disease and consequences. United European Gastroenterol J 2014; 2(5): 345–354.
4. Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology 2013; 144: 1252–1261.
5. Kleeff J, Whitcomb D, Shimosegawa T et al. Chronic pancreatitis. Nature Rev Dis Primers 2017; 3: 17060.
6. Etemad B, Whitcomb DC. Chronic pancreatitis: diagnosis, classification and new genetic developments. Gastroenterology 2001; 120: 682–707.
7. Steer ML, Waxman I, Freedman S. Chronic pancreatitis. N Engl J Med 1995; 332: 1482-1490.
8. Whitcomb DC, Frulloni L, Garg P et al. An international draft consensus proposal for a new mechanistic definition. Pancreatology. 2016; 16: 218–224.
9. Bojková M, Dítě P, Kunovský L, et al. The role of metabolic syndrome in the induction of chronic pancreatitis after a first attack of acute pancreatitis -multicenter trial. Vnitř Lék 2020; 66(8): e12–e16.
10. Bertilsson S, Sward P, Kalaitzakis E. Factors that affect disease progression after first attack of acute pancreatitis. Clinical Gastroenterology and Hepatology 2015; 13: 1662–1669.
11. Ahmed Ali U, Issa Y, Hagenaars JC et al. Risk of recurrent pancreatitis and progression to chronic pancreatitis after a first episode of acute pancreatitis. Clin Gastroenterol Hepatol 2016; 14(5): 738–746.
12. Hoffmeister A, Mayerle J, Beglinger C et al. Definition, aetiology, diagnostic examinations, medical, endoscopic and surgical management of chronic pancreatitis. Z Gastroenterol 2015; 53: 1443–1495.
13. Löhr JM, Dominguez‑Munoz E, Rosendahl J et al. United European Gastroenterology evidence – based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU). United European Gastroenterol Journal 2017; 5(2): 153–199.
14. Shmulewitz A, Teefey SA, Robinson BS et al. Factor affecting image quality and diagnostic efficacy in abdominal sonography: a prospective study of 140 patients. J Clin Ultrasound 1993; 21: 623–630.
15. Perez‑Johnston R, Sainani NI, Sahani DV. Imaging of chronic pancreatitis (including groove and autoimmune pancreatitis). Radiol Clin North Am 2012; 50: 447–466.
16. Anderson SW, Sato JA. Pancreatic duct evaluation: accuracy of portal venous phase 64 MDCT. Abdominal Imaging 2009; 34: 55–64.
17. Dimastromatteo J, Brentnall T, Kelly K. Imaging in pancreatic disease Nature Reviews Gastroenterol Hepatol 2017; 14: 97–109.
18. Sandrasegaran K, Lin C, Akisik FM. et al. State – of‑the‑art pancreatic MRI. AJR Am J Roentgenol 2010; 195: 42–53.
19. Kim T, Murakami T, Takamura M et al. Pancreatic mass due to chronic pancreatitis: correlation of CT and MR imaging features with pathologic findings. AJR Am J Roentgenol 2001; 177(2): 367–371.
20. Catalano MF, Sahai A, Levy M et al. EUS‑based criteria for the diagnosis of chronic pancreatits. The Rosemont classification. Gastrointest Endosc 2009; 69: 1251–1261.
21. Iglesias‑García J, Lariño‑Noia J, Lindkvist B et al. Endoscopic ultrasound in the diagnosis of chronic pancreatitis. Rev Esp Enferm Dig 2015; 107(4): 221–228.
22. Shi Y, Glaser KJ, Venkatesh SK et al. Feasibility usinig 3D MR elastography to determine pancreatic stiffness in healthy volunteers. J Magn Reson Imaging. 2015; 41: 369–375.
23. Tirkes T, Lin C, Fogel EL et al. T1 mapping for the diagnosis of mild chronic pancreatitis. J Magn Reson Imaging. 2017; 45: 1171–1176.
24. Akisik MF, Aisen AM, Sandrasegaran K, Jennings SG, Lin C, Sherman S, Lin JA, Rydberg M. Assessment of chronic pancreatitis: utility of diffusion‑weighted MR imaging with secretin enhancement. Radiology 2009; 250(1): 103–109.
25. Rebours V, Boutron‑Ruault MC, Schnee M et al. The natural history of hereditary pancreatitis: a national series. Gut 2009; 58: 97–103.
26. Németh BC, Sahin‑Tóth M. Human cationic trypsinogen (PRSS1) variants and chronic pancreatitis. Am J Physiol Gastrointest Liver Physiol. 2014; 306: 466–473.
27. Masson E, Chen JM, Scotet V et al. Association of rare chymotrypsinogen C(CTRC) gene variations in patients with idiopathic chronic pancreatitis. Human Genetics 2008; 123: 83–91.
28. Keller J, Layer P. Human pancreatic exocrine response to nutrients in health and disease. Gut 2005; 54Suppl 6: vi1–vi28.
29. Löhr JM. Exocrine pancreatic insufficiency. Uni‑Med Verlag AG 2010. ISBN: 978- 3895992025.
30. Přecechtělová M, Dítě P, Soška V et al. Změny plazmatických hladin vitaminů C a E a volných kyslíkových radikálů u nemocných s chronickou pankreatitidou. Čes a Slov Gastroent 1994; 48 (2): 47–51.
31. Pezzilli R, Andriulli A, Bassi C et al. Exocrine Pancreatic Insufficiency collaborative (EPIc) Group. Exocrine pancreatic insufficiency in adults: a shared position statement of the Italian Association for the Study of the Pancreas. World J Gastroenterol 2013; 19(44): 7930–7946.
32. Domínguez‑Muñoz JE, Drewes AM, Lindkvist B et al. Recommendations from United European Gastronterology evidence‑based guidelines for diagnosis and therapy of chronic pancreatitis. Pancreatology 2018; 18: 847–854.
33. Iglesia D, Avci B, Kiriukova M et al. Pancreatic exocrine insufficiency and pancreatic enzyme replacement therapy in patients with advanced pancreatic cancer: A systematic review and meta‑analysis. United European Gastroenterol Journal 2020; 8(9): 1115–1125.
34. Chaudhary A, Domínguez‑Muñoz JE, Layer P et al. Pancreatic exocrine insufficiency as a complication of gastrointestinal surgery and the impact of pancreatic enzyme replacement therapy. Dig Dis 2020; 38: 53–68.
35. Dutta SK, Rubin J, Harvey J. Comparative evaluation of the therapeutic efficacy of a pH‑sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency. Gastroenterology 1983; 84: 476–482.
36. Warshaw AL, Banks PA, Fernándéz‑Del Castillo C. AGA technical review: treatment of pain in chronic pancreatitis. Gastroenterology 1998; 115: 765–776.
37. Hobbs PM, Johnson WG, Graham DY. Management of pain in chronic pancreatitis with emphasis on exogenous pancreatic enzymes. World J Gastrointest Pharmacol and Ther 2016; 7(3): 370–386.
38. Pitchumoni CS. Chronic pancreatitis: pathogenesis and management of pain. J Clin Gastroenterol 1998; 27: 101–107.
39. Enweluzo C, Tlhabano L. Pain management in chronic pancreatitis: taming the beast. Clin Exp Gastroenterol 2013; 6: 167–171.
40. Talukdar R, Murthy HM, Reddy DN. Role of methionine containing antioxidant combination in the management of pain in chronic pancreatitis: a systematic review. Pancreatology. 2015; 15: 136–144.
41. Winstead NS, Wilcox CM. Clinical trials of pancreatic enzyme replacement for painful chronic pancreatitis--a review. Pancreatology 2009; 9: 344–350.
42. Isaksson G, Ihse I. Pain reduction by an oral pancreatic enzyme preparation in chronic pancreatitis. Dig Dis Sci 1983; 28: 97–102.
Labels
Diabetology Endocrinology Internal medicineArticle was published in
Internal Medicine
2021 Issue 2
Most read in this issue
- Diagnostics and therapy of chronic pancreatitis according to UEG guidelines
- Glucagon in treatment of hypoglycemia – novelties
- Perindopril: a long-term certainty in treating hypertension
- Current view of diagnosis and treatment of latent autoimmune diabetes in adults